- Concept UI
- M0378570
- Scope Note
- Committees established to review interim data and efficacy outcomes in clinical trials. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects (the Common Rule) require (45 CFR 46.111) that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations (21 CFR 50.24) require that such committees be established to monitor studies conducted in emergency settings.
- Terms
-
Clinical Trials Data Monitoring Committees
Preferred Term
Term UI
T436068
Date02/13/2001
LexicalTag
NON
ThesaurusID
-
Data and Safety Monitoring Boards
Term UI
T436069
Date02/13/2001
LexicalTag
NON
ThesaurusID
NLM (2002)
-
Data Monitoring Committees
Term UI
T449952
Date06/11/2001
LexicalTag
NON
ThesaurusID
BIOETHICS (2000)
-
Safety Monitoring Boards
Term UI
T449976
Date06/11/2001
LexicalTag
NON
ThesaurusID
BIOETHICS (2000)